Pandemic vaccines: promises and pitfalls
- 20 November 2006
- journal article
- review article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 185 (S10) , S62-S65
- https://doi.org/10.5694/j.1326-5377.2006.tb00710.x
Abstract
Prototype vaccines against influenza A/H5N1 may be poorly immunogenic, and two or more doses may be required to induce levels of neutralising antibody that are deemed to be protective. The actual le...Keywords
This publication has 10 references indexed in Scilit:
- Immunization with Reverse‐Genetics–Produced H5N1 Influenza Vaccine Protects Ferrets against Homologous and Heterologous ChallengeThe Journal of Infectious Diseases, 2006
- Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trialThe Lancet, 2006
- Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) VaccineNew England Journal of Medicine, 2006
- The virosome concept for influenza vaccinesVaccine, 2005
- Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus ChallengeViral Immunology, 2005
- A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responsesProceedings of the National Academy of Sciences, 2004
- Influenza A Virus with Defective M2 Ion Channel Activity as a Live VaccineVirology, 2002
- Immunogenicity and Protective Efficacy of Replication-Incompetent Influenza Virus-Like ParticlesJournal of Virology, 2002
- Influenza A and B viruses expressing altered NS1 proteins: A vaccine approachProceedings of the National Academy of Sciences, 2000
- DNA Vaccine Encoding Hemagglutinin Provides Protective Immunity against H5N1 Influenza Virus Infection in MiceJournal of Virology, 1999